1. Zhang, Lianmin, Cui, Yanan, Zhou, Guangyao, Zhang, Zhenfa, Zhang, Pengpeng. 2024. Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma. In Journal for immunotherapy of cancer, 12, . doi:10.1136/jitc-2024-010008. https://pubmed.ncbi.nlm.nih.gov/39455097/
2. Zheng, Shutao, He, Shuo, Liang, Yan, Gao, Haidong, Lu, Xiaomei. 2024. NME4 suppresses NFκB2-CCL5 axis, restricting CD8+ T cell tumour infiltration in oesophageal squamous cell carcinoma. In Immunology, 173, 408-421. doi:10.1111/imm.13838. https://pubmed.ncbi.nlm.nih.gov/39016535/
3. Wang, Wenqian, Dong, Ming, Cui, Jie, Dong, Jingcheng, Wei, Ying. 2019. NME4 may enhance non‑small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation. In Molecular medicine reports, 20, 1629-1636. doi:10.3892/mmr.2019.10413. https://pubmed.ncbi.nlm.nih.gov/31257488/
4. Zheng, Shutao, Liu, Qing, Liu, Tao, Han, Xiujuan, Lu, Xiaomei. 2020. NME4 modulates PD-L1 expression via the STAT3 signaling pathway in squamous cell carcinoma. In Biochemical and biophysical research communications, 526, 29-34. doi:10.1016/j.bbrc.2020.03.055. https://pubmed.ncbi.nlm.nih.gov/32192776/
5. Yu, Ji Hea, Jung, Yun Ji, Kim, Myung-Sun, Cho, Sung-Rae, Kim, Young-Han. 2023. Differential Expression of NME4 in Trophoblast Stem-Like Cells and Peripheral Blood Mononuclear Cells of Normal Pregnancy and Preeclampsia. In Journal of Korean medical science, 38, e128. doi:10.3346/jkms.2023.38.e128. https://pubmed.ncbi.nlm.nih.gov/37096311/
6. Garcia-Esparcia, Paula, Hernández-Ortega, Karina, Ansoleaga, Belén, Carmona, Margarita, Ferrer, Isidre. 2015. Purine metabolism gene deregulation in Parkinson's disease. In Neuropathology and applied neurobiology, 41, 926-40. doi:10.1111/nan.12221. https://pubmed.ncbi.nlm.nih.gov/25597950/